Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Novo Nordisk is looking for deals more than ever before, the CEO of the Danish drugmaker said in an interview
Read More
Novo
Stocks making the biggest moves premarket: Novo Nordisk, JPMorgan Chase, United Airlines &
Check out the companies making the biggest moves premarket: Novo Nordisk — U.S.-listed shares popped 3% after the company announced
Read More
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t
Read More
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription
Read More
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Stocks making the biggest moves midday: IBM, AMD, Dillard’s, Novo Nordisk, Keysight
These are the stocks posting the largest moves in midday trading. This article was originally published by a Cnbc.com. Read
Read More
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino’s Pizza and more
Check out the companies making headlines before the bell. Arcellx — The biotech stock surged 78% after Gilead Sciences said
Read More
Stocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger
Check out the companies making headlines before the bell. Oracle — Shares rose 2% after the technology firm received an
Read More
Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18%
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies
Read More